Sudair Pharma proudly took part in CPHI Milan 2024, one of the world’s largest and most influential pharmaceutical exhibitions, participating under the Saudi Made Pavilion to represent the Kingdom’s growing pharmaceutical manufacturing capabilities.
During the event, Sudair Pharma showcased its innovative portfolio, including advanced pharmaceutical formulations, high-quality manufacturing standards, and its strategic projects aimed at localizing essential and specialized medicines in Saudi Arabia.
The company engaged with international partners, industry experts, and global stakeholders to explore opportunities for collaboration, export expansion, and technological exchange. Sudair Pharma’s presence emphasized its role in contributing to the growth of the Saudi pharmaceutical sector and strengthening the Kingdom’s global footprint in healthcare innovation.
Participation in CPHI Milan aligns with Sudair Pharma’s commitment to:
Advancing pharmaceutical localization in line with Vision 2030,
Expanding its presence in global markets,
Showcasing Saudi excellence in innovation and high-standard manufacturing,
Building strategic partnerships that support scientific and industrial development.
Sudair Pharma expressed pride in representing Saudi Arabia at such a prestigious global event, reaffirming its dedication to elevating the Kingdom’s pharmaceutical industry and promoting locally manufactured medicines on the international stage.
